HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
Hims & Hers Health, Inc.
(NYSE:HIMS) will release its second quarter earnings report after the closing bell on Monday, Aug. 10.
Analysts expect the San Francisco, California-based company to report a quarterly loss of 5 cents per share, versus earnings of 17 cents per share in the year-ago period.
The consensus estimate for Hims & Hers Health’s quarterly revenue is $730.12 million.
It reported $544.83 million last year, according to Benzinga Pro.
Hims & Hers Health shares are in the spotlight Monday ahead of its second-quarter earnings report due today after the market…
Hims & Hers posted Q2 results - here are the details you need to know.
Hims & Hers stock falls after Q2 earnings miss estimates despite beating revenue targets. Here is what drove the stock down.
Telehealth platform Hims & Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to…
The telehealth company posted a net loss of $86.3 million in the second quarter while raising its full-year revenue outlook to…
In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart.
